Numerous studies have shown that BMP signalling is maintained in certain tumours such as breast, lung and HNSCC, where tumours overexpress BMP ligands and upregulate the BMP receptors (e.g., BMPR1A). This evidence concerns the gene BMPR1A and neoplasm.